Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

37 The Impact of pH on Antifungal Susceptibility Testing on Vulvovaginal Candidiasis Isolates

View through CrossRef
Abstract Objectives Vulvovaginal candidiasis (VVC) is a common superficial fungal infection primarily caused by Candida albicans (∼70%) or C. glabrata (∼20%). Antimicrobial susceptibility testing (AST) is not indicated for patients with uncomplicated VVC, however, it is appropriate for compliant patients that fail adequate therapy, including repeat infections or recurrent VVC (rVVC; ≥3 events per year). Unlike traditional AST reference methods performed at a neutral pH, yeasts in vulvovaginal tissue are exposed to antifungals at the normal vaginal pH range of 4-4.5. In this study, we hypothesized that VVC clinical isolates will exhibit elevated Minimum Inhibitory Concentrations (MICs) to antifungals when incubated at a pH = 4 vs pH = 7. Methods The minimum inhibitory concentration (MIC) of VVC (n = 43) and systemic (n = 20) isolates was evaluated at a pH = 4 vs 7 using microbroth dilution antimicrobial susceptibility testing (AST) with growth curves determined utilizing absorbance (OD600nm). Changes in cell wall components were assessed using cell-wall targeting dyes: fluorescently tagged wheat germ agglutinin (chitin), calcofluor white (chitin), and concanavalin A (mannoprotein). The impact of pH on the chemical structure of antifungals was determined utilizing 2D nuclear magnetic resonance (NMR). Results 2D nuclear magnetic resonance (NMR) of fluconazole, flucytosine, isavuconazole, and voriconazole showed no difference in the chemical structure at pH = 4, 5.6, or 7. However, peak shifts were observed in both rezafungin and caspofungin, indicating ionization may impact drug efficacy at a pH = 4. Assessment by microbroth dilution revealed that VVC isolates exhibited significantly increased MICs (>2 doubling dilutions) at a pH of 4 vs 7. At 24h, 23% (5/22) of C. albicans and 52% (11/21) of C. glabrata VVC isolates showed elevated MICs to echinocandins. Similarly, 36% (8/22) of C. albicans and 86% (18/21) of C. glabrata VVC isolates exhibited elevated MICs to azoles (posaconazole, voriconazole, itraconazole, fluconazole, and isavuconazole). Only C. albicans (15%; 2/13) showed increased resistance to flucytosine. pH-dependent MIC trends continued at 48 and 72h. VVC isolates exhibited a delay in initial growth at pH = 4 (13.5 hours) vs pH = 7 (2.9 hours), yet grew significantly more by 72h with an area under the curve at pH = 4 (30.2AU) vs pH = 7 (11.6AU). Co-staining with fluorescently tagged cell wall-targeting dyes identified increased chitin but not mannosylated proteins on the fungal cell surface at a pH = 4 vs 7. Conclusions Given that incubation at a pH = 4 results in a) no shift in the chemical structure of clinically relevant azoles, b) elevated MICs to azoles, and c) a selective fungal growth advantage, MIC data generated by AST performed at a pH = 4 may more accurately identify instances of refractory/recurrent vulvovaginal candidiasis requiring therapeutic optimization. Chart reviews are ongoing to examine the clinical impact of these findings.
Title: 37 The Impact of pH on Antifungal Susceptibility Testing on Vulvovaginal Candidiasis Isolates
Description:
Abstract Objectives Vulvovaginal candidiasis (VVC) is a common superficial fungal infection primarily caused by Candida albicans (∼70%) or C.
glabrata (∼20%).
Antimicrobial susceptibility testing (AST) is not indicated for patients with uncomplicated VVC, however, it is appropriate for compliant patients that fail adequate therapy, including repeat infections or recurrent VVC (rVVC; ≥3 events per year).
Unlike traditional AST reference methods performed at a neutral pH, yeasts in vulvovaginal tissue are exposed to antifungals at the normal vaginal pH range of 4-4.
5.
In this study, we hypothesized that VVC clinical isolates will exhibit elevated Minimum Inhibitory Concentrations (MICs) to antifungals when incubated at a pH = 4 vs pH = 7.
Methods The minimum inhibitory concentration (MIC) of VVC (n = 43) and systemic (n = 20) isolates was evaluated at a pH = 4 vs 7 using microbroth dilution antimicrobial susceptibility testing (AST) with growth curves determined utilizing absorbance (OD600nm).
Changes in cell wall components were assessed using cell-wall targeting dyes: fluorescently tagged wheat germ agglutinin (chitin), calcofluor white (chitin), and concanavalin A (mannoprotein).
The impact of pH on the chemical structure of antifungals was determined utilizing 2D nuclear magnetic resonance (NMR).
Results 2D nuclear magnetic resonance (NMR) of fluconazole, flucytosine, isavuconazole, and voriconazole showed no difference in the chemical structure at pH = 4, 5.
6, or 7.
However, peak shifts were observed in both rezafungin and caspofungin, indicating ionization may impact drug efficacy at a pH = 4.
Assessment by microbroth dilution revealed that VVC isolates exhibited significantly increased MICs (>2 doubling dilutions) at a pH of 4 vs 7.
At 24h, 23% (5/22) of C.
albicans and 52% (11/21) of C.
glabrata VVC isolates showed elevated MICs to echinocandins.
Similarly, 36% (8/22) of C.
albicans and 86% (18/21) of C.
glabrata VVC isolates exhibited elevated MICs to azoles (posaconazole, voriconazole, itraconazole, fluconazole, and isavuconazole).
Only C.
albicans (15%; 2/13) showed increased resistance to flucytosine.
pH-dependent MIC trends continued at 48 and 72h.
VVC isolates exhibited a delay in initial growth at pH = 4 (13.
5 hours) vs pH = 7 (2.
9 hours), yet grew significantly more by 72h with an area under the curve at pH = 4 (30.
2AU) vs pH = 7 (11.
6AU).
Co-staining with fluorescently tagged cell wall-targeting dyes identified increased chitin but not mannosylated proteins on the fungal cell surface at a pH = 4 vs 7.
Conclusions Given that incubation at a pH = 4 results in a) no shift in the chemical structure of clinically relevant azoles, b) elevated MICs to azoles, and c) a selective fungal growth advantage, MIC data generated by AST performed at a pH = 4 may more accurately identify instances of refractory/recurrent vulvovaginal candidiasis requiring therapeutic optimization.
Chart reviews are ongoing to examine the clinical impact of these findings.

Related Results

Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
In vitro susceptibility testing of Candida species isolated from blood stream infections to five conventional antifungal drugs
In vitro susceptibility testing of Candida species isolated from blood stream infections to five conventional antifungal drugs
Candida is an opportunistic fungal pathogen which can cause fatal bloodstream infections (BSIs) in immunocompromised and immunodeficient persons. In this study, the susceptibility ...
Phenotypic and Molecular Characterization of the blaTEM Gene in Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
Phenotypic and Molecular Characterization of the blaTEM Gene in Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
Abstract Introduction There has been a notable rise in antibiotic resistance among enterobacteria. This issue is primarily attributed to the emergence of extended-spectrum beta-lac...
Data from Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities
Data from Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities
<div>Abstract<p>Genital tract infections, including vulvovaginal candidiasis and bacterial vaginosis, have emerged as potential modulators of persistent human papilloma...
Data from Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities
Data from Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities
<div>Abstract<p>Genital tract infections, including vulvovaginal candidiasis and bacterial vaginosis, have emerged as potential modulators of persistent human papilloma...
Recurrent Vulvovaginal Candidiasis
Recurrent Vulvovaginal Candidiasis
Vulvovaginal candidiasis is a common fungal infection caused by Candida Sp, especially Candida albicans. Recurrent vulvovaginal candidiasis was defined as the occurrence of four or...
<b>Association Between Recurrent Vulvovaginal Candidiasis and Glycemic Control in Women With Undiagnosed Prediabetes</b>
<b>Association Between Recurrent Vulvovaginal Candidiasis and Glycemic Control in Women With Undiagnosed Prediabetes</b>
Background: Recurrent vulvovaginal candidiasis is a common gynecologic problem that causes repeated symptoms, frequent healthcare visits, and substantial impairment in quality of l...

Back to Top